文献速递角膜与眼表疾病青光眼

青光眼引流装置眼行后弹力层内皮角膜移植的临床结局

Clinical Outcomes of Descemet Membrane Endothelial Keratoplasty in Eyes With a Glaucoma Drainage Device.
PubMed 文献 · Am J Ophthalmol · 2018-11-28

回顾性分析20眼(19例)伴青光眼引流装置(GDD)行DMEK的临床结局,术后平均随访19个月,1年累积移植成功率89%,73%术眼视力提高≥2行,但供体内皮细胞密度显著下降且并发症包括植片脱离和排斥。

要点

  • GDD眼行DMEK需特定手术改良,1年累积移植成功率为89%。
  • 术后1年73%术眼最佳矫正视力提高≥2行,27%保持稳定。
  • 供体内皮细胞密度术后1、6、12个月分别下降37%、60%、71%。

核心结论

  • 在特定手术改良下,考虑到GDD眼的复杂性,DMEK可提供可接受的临床结局。
  • GDD的存在可能缩短植片存活时间并增加再次移植的风险。

研究设计与样本

  • 回顾性、干预性病例系列,在2个三级转诊中心纳入20眼(19例)伴GDD行DMEK的患眼。
  • 共分析23次DMEK手术,适应证为大泡性角膜病变(52%)、既往移植失败(39%)或Fuchs内皮角膜营养不良(9%)。

主要发现

  • 术后平均随访19(±17)个月,Kaplan-Meier分析显示1年累积移植成功率为89%。
  • 术后1年(n=15眼),最佳矫正视力提高≥2 Snellen行者为11眼(73%),保持稳定者为4眼(27%)。
  • 供体内皮细胞密度在术后1、6、12个月分别下降37%(n=14)、60%(n=11)、71%(n=11)。
  • 术后2年内并发症包括瞳孔阻滞1眼(部分抽气后逆转)、需再次注气的显著植片脱离5眼(22%)、局部激素逆转的排斥2眼(9%)、继发植片失败2眼(9%)、3只透明晶状体眼中1只发生白内障(33%)。
  • 2眼(9%)需再次角膜移植。

临床怎么用

  • 对于伴GDD的角膜内皮失代偿眼,DMEK可作为考虑术式,但需采用特定手术改良。
  • 术后需密切监测植片脱离、排斥和内皮细胞密度下降,并告知再次移植风险可能增加。

局限性

  • 回顾性设计,样本量小(20眼),随访时间有限(平均19个月)。
  • 未设对照组,部分结局数据存在缺失(如内皮细胞密度各时间点n值不同)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the feasibility and clinical outcomes of Descemet membrane endothelial keratoplasty (DMEK) in eyes with a glaucoma drainage device (GDD). DESIGN: Retrospective, interventional case series. METHODS: Clinical outcomes of 23 DMEK procedures for bullous keratopathy (52%), failed previous transplant (39%), or Fuchs endothelial corneal dystrophy (9%) in 20 eyes (19 patients) with a GDD were retrospectively analyzed at 2 tertiary referral centers. Main outcome measures were best-corrected visual acuity (BCVA), endothelial cell density (ECD), postoperative complications, and graft survival. RESULTS: Mean length of postoperative follow-up after DMEK was 19 (±17) months. Kaplan-Meier survival analysis showed an 89% cumulative graft success rate at 1 year postoperatively. At 1 year postoperatively (n = 15 eyes), BCVA improved by ≥2 Snellen lines in 11 eyes (73%) and remained stable in 4 eyes (27%). Donor ECD decreased by 37% (n = 14), 60% (n = 11), and 71% (n = 11) at 1, 6, and 12 months postoperatively, respectively. Postoperative complications up to 2 years postoperatively comprised pupillary block in 1 eye (successfully reversed by partial air removal), visually significant graft detachment requiring rebubbling in 5 eyes (22%), allograft rejection successfully reversed with topical steroids in 2 eyes (9%), secondary graft failure in 2 eyes (9%), and cataract in 1 of 3 phakic eyes (33%). Re-keratoplasty was required in 2 eyes (9%). CONCLUSIONS: With specific surgical modifications, DMEK provided acceptable clinical outcomes when taking the complexity of these eyes into account. However, presence of a GDD may reduce graft survival times and may pose a risk for more frequent regrafting.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Birbal RS, Tong CM, Dapena I, et al. Clinical Outcomes of Descemet Membrane Endothelial Keratoplasty in Eyes With a Glaucoma Drainage Device. Am J Ophthalmol. 2018. PMID: 30502334. doi:10.1016/j.ajo.2018.11.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。